164 related articles for article (PubMed ID: 16420784)
41. The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
Liekens S
Verh K Acad Geneeskd Belg; 2002; 64(3):197-224. PubMed ID: 12238243
[TBL] [Abstract][Full Text] [Related]
42. Prevention of fracture healing in rats by an inhibitor of angiogenesis.
Hausman MR; Schaffler MB; Majeska RJ
Bone; 2001 Dec; 29(6):560-4. PubMed ID: 11728927
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
44. The rat Subcutaneous Air Sac model: a quantitative assay of antiangiogenesis in induced vessels.
Lichtenberg J; Hjarnaa PJ; Kristjansen PE; Hansen D; Binderup L
Pharmacol Toxicol; 1999 Jan; 84(1):34-40. PubMed ID: 9974188
[TBL] [Abstract][Full Text] [Related]
45. [Implication of vascular endothelial growth factor (VEGF) in human head and neck cancer].
Ueno Y
Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):163-70. PubMed ID: 16615431
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of angiogenesis in vivo by interleukin 12.
Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
[TBL] [Abstract][Full Text] [Related]
47. Regulation and action of angiogenic factors in the primate ovary.
Stouffer RL; MartÃnez-Chequer JC; Molskness TA; Xu F; Hazzard TM
Arch Med Res; 2001; 32(6):567-75. PubMed ID: 11750732
[TBL] [Abstract][Full Text] [Related]
48. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR.
Egawa S; Tsutsumi M; Konishi Y; Kobari M; Matsuno S; Nagasaki K; Futami H; Yamaguchi K
Gastroenterology; 1995 May; 108(5):1526-33. PubMed ID: 7537236
[TBL] [Abstract][Full Text] [Related]
49. Angiostatic treatment of neuroblastoma.
Wassberg E; Christofferson R
Eur J Cancer; 1997 Oct; 33(12):2020-3. PubMed ID: 9516846
[TBL] [Abstract][Full Text] [Related]
50. Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma.
Qin LX; Tang ZY; Li XM; Bu W; Xia JL
Ann Acad Med Singap; 1999 Jan; 28(1):147-51. PubMed ID: 10374041
[TBL] [Abstract][Full Text] [Related]
51. Setting up of an original computer-assisted methodology to characterize in vitro drug-induced anti-angiogenic effects.
Farinelle S; Dehauwer C; Darro F; Decaestecker C; Fontaine J; Pasteels JL; Van Ham P; Atassi G; Kiss R
Int J Mol Med; 1998 Nov; 2(5):545-53. PubMed ID: 9858650
[TBL] [Abstract][Full Text] [Related]
52. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
Mekapati SB; Hansch C
Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
[TBL] [Abstract][Full Text] [Related]
53. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.
Becker CM; Wright RD; Satchi-Fainaro R; Funakoshi T; Folkman J; Kung AL; D'Amato RJ
Am J Pathol; 2006 Jun; 168(6):2074-84. PubMed ID: 16723720
[TBL] [Abstract][Full Text] [Related]
54. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis.
Peacock DJ; Banquerigo ML; Brahn E
Cell Immunol; 1995 Feb; 160(2):178-84. PubMed ID: 7536634
[TBL] [Abstract][Full Text] [Related]
55. Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors.
Puduvalli VK; Sawaya R
J Neurooncol; 2000; 50(1-2):189-200. PubMed ID: 11245279
[TBL] [Abstract][Full Text] [Related]
56. TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy.
Teicher BA; Emi Y; Kakeji Y; Northey D
Eur J Cancer; 1996 Dec; 32A(14):2461-6. PubMed ID: 9059334
[No Abstract] [Full Text] [Related]
57. Adipose tissue mass can be regulated through the vasculature.
Rupnick MA; Panigrahy D; Zhang CY; Dallabrida SM; Lowell BB; Langer R; Folkman MJ
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10730-5. PubMed ID: 12149466
[TBL] [Abstract][Full Text] [Related]
58. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi S; O'Reilly M; Christofori G; Holmgren L; Grosfeld J; Folkman J; Hanahan D
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2002-7. PubMed ID: 8700875
[TBL] [Abstract][Full Text] [Related]
59. Postoperative progression of pulmonary metastasis in osteosarcoma.
Tsunemi T; Nagoya S; Kaya M; Kawaguchi S; Wada T; Yamashita T; Ishii S
Clin Orthop Relat Res; 2003 Feb; (407):159-66. PubMed ID: 12567143
[TBL] [Abstract][Full Text] [Related]
60. Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma.
Ryschich E; Werner J; Gebhard MM; Klar E; Schmidt J
Pancreas; 2003 Mar; 26(2):166-72. PubMed ID: 12604915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
